Skip to main content
. Author manuscript; available in PMC: 2016 Oct 14.
Published in final edited form as: Cancer Transl Med. 2016 Feb 28;2(1):1–6. doi: 10.4103/2395-3977.177555

Figure 4.

Figure 4

(a and b) Kaplan–Meier survival analysis of miR-192 (P = 0.027) (P = 0.003) (c and d) thymidylate synthase (P = 0.038) (P = 0.051) (e and f) Per1 (P = 0.10) (P = 0.79) (g and h) and miR-194 (P = 0.36) (P = 0.045) in Stage II, Stage III and IV colorectal cancer